Who owns the APERSURE trademark?

The APERSURE trademark is owned by HYPERION DEFI, INC..

What class is the APERSURE trademark registered in?

The APERSURE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for APERSURE?

The USPTO serial number for APERSURE is 90759191.

What is the registration number for APERSURE?

APERSURE is registered under USPTO registration number 6771951.

Sealvo

Home Search: APERSUREAPERSURE #90759191

Back

Updated Oct 24, 2026·8 searches this week

View on USPTO TSDR Find similar marks

APE

USPTO Trademark Record

REGISTERED

APERSURE

SN 90759191·Reg 6771951·Filed Jun 07, 2021

Owner HYPERION DEFI, INC.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

APERSURE (Serial No. 90759191), Registration No. 6771951, is a registered US trademark filed on Jun 07, 2021 by HYPERION DEFI, INC.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: June 28, 2028

Mark Intelligence

APERSURE (Reg. #6771951) is a registered US trademark that has been protecting its owner, HYPERION DEFI, INC., since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 07, 2021

SERIAL

90759191

REG#

6771951

REGISTERED

Jun 28, 2022

Filing Information

StatusREGISTERED

Filing DateJun 07, 2021

Serial Number90759191

Registration No.6771951

Registration DateJun 28, 2022

Status DateJun 28, 2022

Published for OppositionApr 12, 2022

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Dec 31, 2021

First use in commerce: Dec 31, 2021

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

23 events

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Aug 21, 2025

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

REGISTERED-PRINCIPAL REGISTER

Jun 28, 2022

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 28, 2022

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Apr 12, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 12, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 23, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Mar 09, 2022

ASSIGNED TO LIE

LAW OFFICE PUBLICATION REVIEW COMPLETED

Mar 09, 2022

LAW OFFICE PUBLICATION REVIEW COMPLETED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 07, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 02, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 01, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 01, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Feb 24, 2022

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

ASSIGNED TO EXAMINER

Feb 23, 2022

ASSIGNED TO EXAMINER

USE AMENDMENT ACCEPTED

Feb 23, 2022

USE AMENDMENT ACCEPTED

NON-FINAL ACTION WRITTEN

Feb 23, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 23, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 23, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

USE AMENDMENT FILED

Feb 01, 2022

USE AMENDMENT FILED

AMENDMENT TO USE PROCESSING COMPLETE

Feb 01, 2022

AMENDMENT TO USE PROCESSING COMPLETE

TEAS AMENDMENT OF USE RECEIVED

Jan 31, 2022

TEAS AMENDMENT OF USE RECEIVED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 27, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 10, 2021

NEW APPLICATION ENTERED

Other Marks by HYPERION DEFI, INC.

Additional USPTO filings from the same owner.

EYE

EYENOVIA

86566367

HYPERION DEFI, INC.

REGISTERED

MYD

MYDCOMBI

97808709

HYPERION DEFI, INC.

REGISTERED

MYD

MYDCOMBI

88923446

HYPERION DEFI, INC.

REGISTERED

EYE

EYENOVIA

97011370

HYPERION DEFI, INC.

REGISTERED

Other Marks by Karen Won

Additional USPTO filings handled by the same attorney of record.

NEF

NEFFY

88527539

REGISTERED

MYR

MY ROMVIMZA

99256741

REGISTERED

DEC

DECIPHERA ACCESSPOINT

99234759

REGISTERED

REP

REPLICATE

97157972

REGISTERED

APERSURE

Run a conflict check

Other Marks by HYPERION DEFI, INC.

Other Marks by Karen Won

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company